SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-073633
Filing Date
2015-03-02
Accepted
2015-03-02 17:15:40
Documents
4
Period of Report
2015-02-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d883316d8k.htm 8-K 14177
2 EX-99.1 d883316dex991.htm EX-99.1 32822
3 EX-99.2 d883316dex992.htm EX-99.2 21612
4 GRAPHIC g883316img1.jpg GRAPHIC 8471
  Complete submission text file 0001193125-15-073633.txt   81707
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36500 | Film No.: 15665867
SIC: 2834 Pharmaceutical Preparations